EventsDrive data integrity & unlock insight to accelerate innovation

Event | Oct 4-5, 2022


Drive data integrity & unlock insight to accelerate innovation

IDBS exhibited at The European Laboratory Research & Innovation Group (ELRIG)’s conference, DRUG DISCOVERY 2022, in London.

Contact our experts to learn how our software solutions can help you build strong foundations for your data management, to drive data integrity and unlock the power of predictive models.

Read our related article in the DDW ELRIG UK Drug Discovery 2022 Supplement.

Take full advantage of new approaches to screening and in silico modelling to expedite drug discovery. 

Streamline preclinical screening and safety studies with bio analysis pre-configured workflows and real-time QC that ensure data integrity, quality, and reproducibility.

Learn more


About ELRIG:

WELCOME TO DRUG DISCOVERY 2022 ELRIG’s annual Drug Discovery meeting which remains Europe’s largest meeting for life sciences industry professionals. During this conference, ELRIG will celebrate its long history of hosting disruptive and innovative drug discovery technology developments, whilst exploring the next life science revolutions.

Since the pandemic, Drug Discovery and scientific achievements have reached into people’s lives in way not seen before. This has driven support for diverse and collaborative thinking to make unprecedented scientific progress. The ELRIG community are now facing an exciting prospect to help drive this renaissance in life sciences.

Drug Discovery 2022 promises to provide a platform for the whole drug discovery community to meet at a free to attend, in-person event. ELRIG has partnered with; BPS, SLAS, and RSC to draw together an exciting and progressive 2-day event containing; cutting-edge advancements in screening, automation and high content imaging, and innovations in disease models, advances in cell and gene therapies, revolutions through partnerships, future perspectives in medicinal and green chemistry and finally creative thinking to deliver therapies to one of the most challenging diseases facing society; COPD.